David Hsieh, MD
University of Texas Southwestern Medical Center · Assistant Professor
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Hsieh, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:06 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07878689 · Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular CarcinomaUniversity of Texas Southwestern Medical Center · not yet recruiting · Hepatocellular Carcinoma (HCC) · principal investigator
- Ph2NCT07689175 · Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular CarcinomaUniversity of Texas Southwestern Medical Center · recruiting · Hepatocellular Carcinoma (HCC) · principal investigator
- Ph2NCT06789848 · Ligufalimab and Cadonilimab in Advanced Liver CancersUniversity of Texas Southwestern Medical Center · recruiting · Advanced Hepatocellular Carcinoma, Refractory Hepatocellular Carcinoma, Biliary Tract Cancer · principal investigator
- Ph2NCT05724563 · Domvanalimab and Zimberelimab in Advanced Liver CancersUniversity of Texas Southwestern Medical Center · active not recruiting · Hepatobiliary Cancer, Liver Cancer, Cholangiocarcinoma · principal investigator
- Ph2NCT05537402 · LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCCUniversity of Texas Southwestern Medical Center · terminated · Hepatocellular Carcinoma · principal investigator
- Ph2NCT05249569 · Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular CarcinomaUniversity of Texas Southwestern Medical Center · terminated · Hepatocellular Carcinoma · principal investigator
- Ph2NCT03519997 · A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular CarcinomaDavid Hsieh · completed · Hepatocellular Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.